NewslettersNeural Cell News Telomerase Inhibition Is an Effective Therapeutic Strategy in TERT Promoter Mutant-Glioblastoma Models with Low Tumor Volume By Jamie Kang - January 31, 2023 0 Researchers used CRISPR interference to knock down TERT expression in TERT promoter-mutant glioblastoma cell lines and patient-derived models. They then measured viability using serial proliferation assays. [Neuro-Oncology] Abstract